The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I study of temsirolimus plus erlotinib in patients with refractory solid tumors.
 
Andrea Wang-Gillam
Consulting or Advisory Role - Merrimack; pfizer
Research Funding - Aduro Biotech (Inst); AstraZeneca (Inst); EMD Serono (Inst); Halozyme (Inst); Merrimack (Inst); Newlink Genetics (Inst); OncoMed (Inst); pfizer (Inst); Precision Therapeutics (Inst); Prometheus (Inst)
 
Benjamin R. Tan
Consulting or Advisory Role - Roche/Genentech
Research Funding - Bayer; Eisai; Exelixis; Lilly; Merck Serono; Pfizer; Roche/Genentech; Xcovery
 
Saiama Naheed Waqar
Research Funding - Daiichi Sankyo (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Lilly (Inst); Newlink Genetics (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Spectrum Pharmaceuticals (Inst)
 
Rama Suresh
No Relationships to Disclose
 
Daniel Morgensztern
Consulting or Advisory Role - Celgene
Speakers' Bureau - Boehringer Ingelheim
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); GlaxoSmithKline (Inst); Heat biologics (Inst); Merck (Inst); Verastem (Inst)
 
Brian Andrew Van Tine
Honoraria - AdventRx Pharmaceuticals; DFINE; EMD Serono; GlaxoSmithKline; Johnson & Johnson; Lilly; Novartis; ZIOPHARM Oncology
Consulting or Advisory Role - AdventRx Pharmaceuticals; DFINE; EMD Serono; GlaxoSmithKline; Johnson & Johnson; Lilly; Novartis; ZIOPHARM Oncology
Speakers' Bureau - Caris Life Sciences; DFINE; GlaxoSmithKline
Research Funding - Polaris (Inst)
Expert Testimony - AB Science
Travel, Accommodations, Expenses - ZIOPHARM Oncology
 
Rebecca Nieman
No Relationships to Disclose
 
Ramaswamy Govindan
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - Abbvie; Boehringer Ingelheim; Celgene; Clovis Oncology; Genentech/Roche; GlaxoSmithKline; Helsinn Therapeutics; Merck; Pfizer
Research Funding - Abbvie (Inst); Bayer (Inst); GlaxoSmithKline (Inst); MethylGene (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Celgene; Merck
 
Albert C. Lockhart
Research Funding - Amgen (Inst); Bayer (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Lilly (Inst); Millennium (Inst); Novartis (Inst); Sanofi (Inst); Teva (Inst); Zenyaku Kogyo (Inst)